Biocon Biologics Gets Positive CHMP Opinion for Denosumab
April 28, 2025
Biocon Biologics Ltd , a fully integrated global biosimilars company and subsidiary of Biocon Ltd announced that the Committee for Medicinal Products for Human Use (CHMP)